ID

38383

Beschreibung

Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01671332

Link

https://clinicaltrials.gov/show/NCT01671332

Stichworte

  1. 14.10.19 14.10.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

14. Oktober 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Carcinoma, Non Small Cell Lung NCT01671332

Eligibility Carcinoma, Non Small Cell Lung NCT01671332

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
pathologically proven diagnosis of non-small cell lung cancer
Beschreibung

Non-Small Cell Lung Carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0007131
documented disease progression after first-line chemotherapy for non-small cell lung cancer
Beschreibung

Disease Progression | First line Chemotherapy Non-Small Cell Lung Carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2,1]
C1708063
UMLS CUI [2,2]
C0392920
UMLS CUI [2,3]
C0007131
stable and treated cns metastasis is allowed
Beschreibung

CNS metastases Stable Treated

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0205360
UMLS CUI [1,3]
C1522326
radiation must be completed at least 2 weeks prior to starting protocol treatment
Beschreibung

Therapeutic radiology procedure Completed

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0205197
major surgery must be completed at least 4 weeks prior to starting protocol treatment
Beschreibung

Major surgery Completed

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0679637
UMLS CUI [1,2]
C0205197
ecog performance status 0-2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
sexually active patients must use adequate contraception
Beschreibung

Patients Sexually active Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0241028
UMLS CUI [1,3]
C0700589
adequate bone marrow function
Beschreibung

Bone Marrow function

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
adequate renal function
Beschreibung

Renal function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232804
adequate liver function
Beschreibung

Liver function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232741
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
severe hypersensitivity reaction to docetaxel
Beschreibung

Severe allergy Docetaxel

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2945656
UMLS CUI [1,2]
C0246415
pre-existing grade 3 or 4 neuropathy
Beschreibung

Neuropathy Pre-existing CTCAE Grades

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0442874
UMLS CUI [1,2]
C2347662
UMLS CUI [1,3]
C1516728
women who are pregnant or breastfeeding
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
uncontrolled intercurrent illness
Beschreibung

Comorbidity Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205318
receipt of 3 or more prior chemotherapy regimens
Beschreibung

Prior Chemotherapy Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1265611

Ähnliche Modelle

Eligibility Carcinoma, Non Small Cell Lung NCT01671332

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma
Item
pathologically proven diagnosis of non-small cell lung cancer
boolean
C0007131 (UMLS CUI [1])
Disease Progression | First line Chemotherapy Non-Small Cell Lung Carcinoma
Item
documented disease progression after first-line chemotherapy for non-small cell lung cancer
boolean
C0242656 (UMLS CUI [1])
C1708063 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C0007131 (UMLS CUI [2,3])
CNS metastases Stable Treated
Item
stable and treated cns metastasis is allowed
boolean
C0686377 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C1522326 (UMLS CUI [1,3])
Therapeutic radiology procedure Completed
Item
radiation must be completed at least 2 weeks prior to starting protocol treatment
boolean
C1522449 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
Major surgery Completed
Item
major surgery must be completed at least 4 weeks prior to starting protocol treatment
boolean
C0679637 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Patients Sexually active Contraceptive methods
Item
sexually active patients must use adequate contraception
boolean
C0030705 (UMLS CUI [1,1])
C0241028 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,3])
Bone Marrow function
Item
adequate bone marrow function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
Renal function
Item
adequate renal function
boolean
C0232804 (UMLS CUI [1])
Liver function
Item
adequate liver function
boolean
C0232741 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Severe allergy Docetaxel
Item
severe hypersensitivity reaction to docetaxel
boolean
C2945656 (UMLS CUI [1,1])
C0246415 (UMLS CUI [1,2])
Neuropathy Pre-existing CTCAE Grades
Item
pre-existing grade 3 or 4 neuropathy
boolean
C0442874 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
Pregnancy | Breast Feeding
Item
women who are pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Comorbidity Uncontrolled
Item
uncontrolled intercurrent illness
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Prior Chemotherapy Quantity
Item
receipt of 3 or more prior chemotherapy regimens
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video